Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO31159 | Rauvolfia vomitoria | Species | Apocynaceae | Eukaryota | TCM_Taiwan* | |||
NPO31253 | Rauvolfia serpentina | Species | Apocynaceae | Eukaryota | TCM_Taiwan* | |||
NPO19864 | Fortunes bossfern rhizome | NA | NA | NA | TCMSP* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT26 | Individual Protein | Reverse transcriptase | Human immunodeficiency virus 1 | IC50 | > | 200 | ug/ml | 1710653 |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 7943.3 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 7079.5 | nM | PubChem BioAssay data set |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 7079.5 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 1122 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 3981.1 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 379.3 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT445 | Individual Protein | Peripheral myelin protein 22 | Rattus norvegicus | Potency | 3978.1 | nM | PubChem BioAssay data set | |
NPT445 | Individual Protein | Peripheral myelin protein 22 | Rattus norvegicus | Potency | 907.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 5102.8 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 3349.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 14963.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1188.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 841.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1059.3 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 21313.8 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 3757.8 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 2131.4 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 8412.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 3349.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 33491.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4216.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8412.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11985.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 29849.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1188.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 31622.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 14125.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26603.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 15848.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3548.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13333.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26832.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21131.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6682.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 15089 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2113.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1198.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7497.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10590.9 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 18995.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 600.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 12589.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21313.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1678.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2391.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1059.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11883.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5308 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5955.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2511.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8912.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5011.9 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC191489 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9827 | High Similarity | NPC315634 |
0.9827 | High Similarity | NPC88923 |
0.9827 | High Similarity | NPC100734 |
0.961 | High Similarity | NPC284685 |
0.8362 | Intermediate Similarity | NPC21638 |
0.8034 | Intermediate Similarity | NPC472099 |
0.8033 | Intermediate Similarity | NPC113455 |
0.8023 | Intermediate Similarity | NPC471303 |
0.8017 | Intermediate Similarity | NPC152768 |
0.8017 | Intermediate Similarity | NPC148183 |
0.8008 | Intermediate Similarity | NPC120239 |
0.8 | Intermediate Similarity | NPC476429 |
0.7897 | Intermediate Similarity | NPC318068 |
0.7884 | Intermediate Similarity | NPC476999 |
0.7884 | Intermediate Similarity | NPC474688 |
0.7878 | Intermediate Similarity | NPC304837 |
0.7878 | Intermediate Similarity | NPC476258 |
0.7851 | Intermediate Similarity | NPC474192 |
0.7851 | Intermediate Similarity | NPC475720 |
0.7846 | Intermediate Similarity | NPC475844 |
0.7835 | Intermediate Similarity | NPC129897 |
0.7828 | Intermediate Similarity | NPC154922 |
0.7826 | Intermediate Similarity | NPC478083 |
0.7823 | Intermediate Similarity | NPC124313 |
0.7819 | Intermediate Similarity | NPC473105 |
0.7815 | Intermediate Similarity | NPC280272 |
0.7792 | Intermediate Similarity | NPC476436 |
0.7787 | Intermediate Similarity | NPC90875 |
0.7759 | Intermediate Similarity | NPC478078 |
0.7757 | Intermediate Similarity | NPC237901 |
0.7757 | Intermediate Similarity | NPC195788 |
0.7756 | Intermediate Similarity | NPC472589 |
0.7754 | Intermediate Similarity | NPC169402 |
0.7742 | Intermediate Similarity | NPC207283 |
0.7742 | Intermediate Similarity | NPC84164 |
0.7738 | Intermediate Similarity | NPC473800 |
0.7734 | Intermediate Similarity | NPC89549 |
0.7733 | Intermediate Similarity | NPC475816 |
0.7714 | Intermediate Similarity | NPC476220 |
0.7714 | Intermediate Similarity | NPC160113 |
0.7705 | Intermediate Similarity | NPC233334 |
0.7701 | Intermediate Similarity | NPC473639 |
0.7677 | Intermediate Similarity | NPC472588 |
0.7669 | Intermediate Similarity | NPC116238 |
0.7668 | Intermediate Similarity | NPC67401 |
0.7668 | Intermediate Similarity | NPC183537 |
0.7668 | Intermediate Similarity | NPC181081 |
0.766 | Intermediate Similarity | NPC472098 |
0.7654 | Intermediate Similarity | NPC311906 |
0.7647 | Intermediate Similarity | NPC303374 |
0.7647 | Intermediate Similarity | NPC478080 |
0.7647 | Intermediate Similarity | NPC96321 |
0.7642 | Intermediate Similarity | NPC294909 |
0.7642 | Intermediate Similarity | NPC128265 |
0.7642 | Intermediate Similarity | NPC254240 |
0.7642 | Intermediate Similarity | NPC199851 |
0.7642 | Intermediate Similarity | NPC312870 |
0.764 | Intermediate Similarity | NPC260909 |
0.7631 | Intermediate Similarity | NPC119134 |
0.7631 | Intermediate Similarity | NPC477066 |
0.7629 | Intermediate Similarity | NPC300156 |
0.7625 | Intermediate Similarity | NPC280799 |
0.7623 | Intermediate Similarity | NPC24019 |
0.7615 | Intermediate Similarity | NPC52254 |
0.761 | Intermediate Similarity | NPC81939 |
0.76 | Intermediate Similarity | NPC478081 |
0.7593 | Intermediate Similarity | NPC144452 |
0.7585 | Intermediate Similarity | NPC264176 |
0.7583 | Intermediate Similarity | NPC174760 |
0.7581 | Intermediate Similarity | NPC476995 |
0.7581 | Intermediate Similarity | NPC182907 |
0.7581 | Intermediate Similarity | NPC189903 |
0.7579 | Intermediate Similarity | NPC475666 |
0.7573 | Intermediate Similarity | NPC473041 |
0.7573 | Intermediate Similarity | NPC82070 |
0.7571 | Intermediate Similarity | NPC253675 |
0.757 | Intermediate Similarity | NPC15406 |
0.757 | Intermediate Similarity | NPC188400 |
0.755 | Intermediate Similarity | NPC166722 |
0.7549 | Intermediate Similarity | NPC17437 |
0.7549 | Intermediate Similarity | NPC1608 |
0.754 | Intermediate Similarity | NPC108342 |
0.7539 | Intermediate Similarity | NPC329982 |
0.753 | Intermediate Similarity | NPC478082 |
0.753 | Intermediate Similarity | NPC477067 |
0.7529 | Intermediate Similarity | NPC77878 |
0.7521 | Intermediate Similarity | NPC4687 |
0.752 | Intermediate Similarity | NPC217176 |
0.752 | Intermediate Similarity | NPC474701 |
0.751 | Intermediate Similarity | NPC274640 |
0.751 | Intermediate Similarity | NPC184680 |
0.75 | Intermediate Similarity | NPC46561 |
0.75 | Intermediate Similarity | NPC39370 |
0.75 | Intermediate Similarity | NPC215837 |
0.75 | Intermediate Similarity | NPC471304 |
0.749 | Intermediate Similarity | NPC49672 |
0.749 | Intermediate Similarity | NPC475271 |
0.7489 | Intermediate Similarity | NPC195461 |
0.7489 | Intermediate Similarity | NPC81654 |
0.7489 | Intermediate Similarity | NPC79129 |
0.7489 | Intermediate Similarity | NPC249150 |
0.7489 | Intermediate Similarity | NPC313985 |
0.7489 | Intermediate Similarity | NPC49196 |
0.748 | Intermediate Similarity | NPC470785 |
0.7479 | Intermediate Similarity | NPC39500 |
0.7479 | Intermediate Similarity | NPC198503 |
0.7479 | Intermediate Similarity | NPC45190 |
0.747 | Intermediate Similarity | NPC57453 |
0.747 | Intermediate Similarity | NPC295228 |
0.7469 | Intermediate Similarity | NPC157931 |
0.746 | Intermediate Similarity | NPC329631 |
0.746 | Intermediate Similarity | NPC22481 |
0.746 | Intermediate Similarity | NPC473540 |
0.7458 | Intermediate Similarity | NPC305984 |
0.7448 | Intermediate Similarity | NPC146976 |
0.7446 | Intermediate Similarity | NPC207620 |
0.7437 | Intermediate Similarity | NPC310211 |
0.7437 | Intermediate Similarity | NPC308137 |
0.7431 | Intermediate Similarity | NPC475648 |
0.7419 | Intermediate Similarity | NPC473186 |
0.7419 | Intermediate Similarity | NPC169716 |
0.7417 | Intermediate Similarity | NPC476114 |
0.741 | Intermediate Similarity | NPC470784 |
0.7409 | Intermediate Similarity | NPC476998 |
0.7409 | Intermediate Similarity | NPC476996 |
0.7407 | Intermediate Similarity | NPC477903 |
0.7406 | Intermediate Similarity | NPC236668 |
0.7403 | Intermediate Similarity | NPC50503 |
0.7395 | Intermediate Similarity | NPC87413 |
0.7393 | Intermediate Similarity | NPC302807 |
0.7388 | Intermediate Similarity | NPC477900 |
0.7388 | Intermediate Similarity | NPC26881 |
0.7388 | Intermediate Similarity | NPC477899 |
0.7383 | Intermediate Similarity | NPC270515 |
0.7381 | Intermediate Similarity | NPC253482 |
0.7381 | Intermediate Similarity | NPC168922 |
0.7377 | Intermediate Similarity | NPC210434 |
0.7377 | Intermediate Similarity | NPC477788 |
0.7374 | Intermediate Similarity | NPC116701 |
0.7373 | Intermediate Similarity | NPC107123 |
0.7373 | Intermediate Similarity | NPC249583 |
0.7368 | Intermediate Similarity | NPC66777 |
0.7368 | Intermediate Similarity | NPC476997 |
0.7368 | Intermediate Similarity | NPC476994 |
0.7368 | Intermediate Similarity | NPC471762 |
0.7366 | Intermediate Similarity | NPC150239 |
0.7366 | Intermediate Similarity | NPC225279 |
0.736 | Intermediate Similarity | NPC327769 |
0.7357 | Intermediate Similarity | NPC196251 |
0.7357 | Intermediate Similarity | NPC102338 |
0.7357 | Intermediate Similarity | NPC111602 |
0.7357 | Intermediate Similarity | NPC63199 |
0.7355 | Intermediate Similarity | NPC184408 |
0.7354 | Intermediate Similarity | NPC203373 |
0.7352 | Intermediate Similarity | NPC210296 |
0.7344 | Intermediate Similarity | NPC3207 |
0.734 | Intermediate Similarity | NPC9482 |
0.7339 | Intermediate Similarity | NPC278525 |
0.7339 | Intermediate Similarity | NPC91125 |
0.7338 | Intermediate Similarity | NPC328928 |
0.7338 | Intermediate Similarity | NPC471978 |
0.7333 | Intermediate Similarity | NPC284141 |
0.7328 | Intermediate Similarity | NPC473833 |
0.7328 | Intermediate Similarity | NPC211920 |
0.7321 | Intermediate Similarity | NPC471979 |
0.732 | Intermediate Similarity | NPC96584 |
0.732 | Intermediate Similarity | NPC255800 |
0.7317 | Intermediate Similarity | NPC473449 |
0.7309 | Intermediate Similarity | NPC201508 |
0.7309 | Intermediate Similarity | NPC316841 |
0.7306 | Intermediate Similarity | NPC235364 |
0.7302 | Intermediate Similarity | NPC6786 |
0.7295 | Intermediate Similarity | NPC323969 |
0.7295 | Intermediate Similarity | NPC469439 |
0.7291 | Intermediate Similarity | NPC475406 |
0.7287 | Intermediate Similarity | NPC134637 |
0.7284 | Intermediate Similarity | NPC469594 |
0.7284 | Intermediate Similarity | NPC247803 |
0.7284 | Intermediate Similarity | NPC174788 |
0.7283 | Intermediate Similarity | NPC217554 |
0.728 | Intermediate Similarity | NPC13603 |
0.7276 | Intermediate Similarity | NPC51388 |
0.7273 | Intermediate Similarity | NPC82472 |
0.7269 | Intermediate Similarity | NPC172355 |
0.7265 | Intermediate Similarity | NPC329793 |
0.7262 | Intermediate Similarity | NPC473187 |
0.7262 | Intermediate Similarity | NPC327904 |
0.7262 | Intermediate Similarity | NPC272549 |
0.7262 | Intermediate Similarity | NPC38959 |
0.7261 | Intermediate Similarity | NPC221100 |
0.7261 | Intermediate Similarity | NPC234078 |
0.7258 | Intermediate Similarity | NPC477787 |
0.7258 | Intermediate Similarity | NPC257851 |
0.7258 | Intermediate Similarity | NPC228377 |
0.7258 | Intermediate Similarity | NPC328186 |
0.7258 | Intermediate Similarity | NPC122968 |
0.7258 | Intermediate Similarity | NPC124029 |
0.7257 | Intermediate Similarity | NPC472111 |
0.7255 | Intermediate Similarity | NPC166712 |
0.7254 | Intermediate Similarity | NPC298436 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC191489 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD7708 | Approved |
0.9827 | High Similarity | NPD7803 | Approved |
0.961 | High Similarity | NPD7956 | Approved |
0.961 | High Similarity | NPD7955 | Approved |
0.8075 | Intermediate Similarity | NPD4885 | Approved |
0.7757 | Intermediate Similarity | NPD8466 | Approved |
0.7757 | Intermediate Similarity | NPD8465 | Approved |
0.7757 | Intermediate Similarity | NPD8467 | Approved |
0.7747 | Intermediate Similarity | NPD4926 | Clinical (unspecified phase) |
0.7733 | Intermediate Similarity | NPD7886 | Phase 2 |
0.7733 | Intermediate Similarity | NPD7885 | Phase 2 |
0.7701 | Intermediate Similarity | NPD7690 | Clinical (unspecified phase) |
0.7642 | Intermediate Similarity | NPD4501 | Approved |
0.7642 | Intermediate Similarity | NPD4500 | Approved |
0.764 | Intermediate Similarity | NPD8426 | Approved |
0.764 | Intermediate Similarity | NPD8459 | Approved |
0.764 | Intermediate Similarity | NPD8425 | Approved |
0.764 | Intermediate Similarity | NPD8460 | Approved |
0.7639 | Intermediate Similarity | NPD5658 | Approved |
0.7628 | Intermediate Similarity | NPD6525 | Clinical (unspecified phase) |
0.7628 | Intermediate Similarity | NPD5482 | Discontinued |
0.7623 | Intermediate Similarity | NPD8429 | Approved |
0.7623 | Intermediate Similarity | NPD8428 | Approved |
0.7623 | Intermediate Similarity | NPD8427 | Approved |
0.761 | Intermediate Similarity | NPD5483 | Clinical (unspecified phase) |
0.7588 | Intermediate Similarity | NPD8091 | Phase 3 |
0.7573 | Intermediate Similarity | NPD5632 | Approved |
0.7549 | Intermediate Similarity | NPD8358 | Approved |
0.7529 | Intermediate Similarity | NPD8363 | Approved |
0.7529 | Intermediate Similarity | NPD6503 | Clinical (unspecified phase) |
0.7529 | Intermediate Similarity | NPD8364 | Approved |
0.7521 | Intermediate Similarity | NPD6160 | Clinical (unspecified phase) |
0.749 | Intermediate Similarity | NPD7417 | Discontinued |
0.7489 | Intermediate Similarity | NPD4600 | Approved |
0.7489 | Intermediate Similarity | NPD4601 | Approved |
0.7473 | Intermediate Similarity | NPD6745 | Discontinued |
0.7472 | Intermediate Similarity | NPD8365 | Clinical (unspecified phase) |
0.746 | Intermediate Similarity | NPD6741 | Clinical (unspecified phase) |
0.746 | Intermediate Similarity | NPD6716 | Phase 1 |
0.7451 | Intermediate Similarity | NPD8350 | Clinical (unspecified phase) |
0.7409 | Intermediate Similarity | NPD4952 | Phase 3 |
0.7403 | Intermediate Similarity | NPD8463 | Approved |
0.7381 | Intermediate Similarity | NPD2921 | Clinical (unspecified phase) |
0.7373 | Intermediate Similarity | NPD5488 | Discontinued |
0.7348 | Intermediate Similarity | NPD5450 | Discontinued |
0.7338 | Intermediate Similarity | NPD8489 | Phase 1 |
0.7331 | Intermediate Similarity | NPD3006 | Discontinued |
0.7328 | Intermediate Similarity | NPD7994 | Phase 2 |
0.7322 | Intermediate Similarity | NPD6567 | Clinical (unspecified phase) |
0.732 | Intermediate Similarity | NPD4373 | Phase 2 |
0.7312 | Intermediate Similarity | NPD7025 | Clinical (unspecified phase) |
0.7306 | Intermediate Similarity | NPD6824 | Clinical (unspecified phase) |
0.73 | Intermediate Similarity | NPD7862 | Clinical (unspecified phase) |
0.7295 | Intermediate Similarity | NPD6242 | Discontinued |
0.7284 | Intermediate Similarity | NPD7395 | Discontinued |
0.7255 | Intermediate Similarity | NPD1483 | Discontinued |
0.7233 | Intermediate Similarity | NPD5805 | Approved |
0.7231 | Intermediate Similarity | NPD7859 | Phase 2 |
0.7222 | Intermediate Similarity | NPD4118 | Clinical (unspecified phase) |
0.7211 | Intermediate Similarity | NPD7796 | Approved |
0.7211 | Intermediate Similarity | NPD7797 | Approved |
0.7197 | Intermediate Similarity | NPD6228 | Discontinued |
0.7191 | Intermediate Similarity | NPD6773 | Clinical (unspecified phase) |
0.719 | Intermediate Similarity | NPD7571 | Clinical (unspecified phase) |
0.7189 | Intermediate Similarity | NPD7268 | Clinical (unspecified phase) |
0.7184 | Intermediate Similarity | NPD6770 | Approved |
0.7181 | Intermediate Similarity | NPD8102 | Discontinued |
0.7167 | Intermediate Similarity | NPD4506 | Discontinued |
0.716 | Intermediate Similarity | NPD5903 | Approved |
0.716 | Intermediate Similarity | NPD5902 | Approved |
0.7131 | Intermediate Similarity | NPD7589 | Clinical (unspecified phase) |
0.7131 | Intermediate Similarity | NPD5479 | Discontinued |
0.7106 | Intermediate Similarity | NPD5071 | Phase 2 |
0.7103 | Intermediate Similarity | NPD6962 | Phase 2 |
0.709 | Intermediate Similarity | NPD5293 | Phase 2 |
0.7085 | Intermediate Similarity | NPD5930 | Phase 3 |
0.7078 | Intermediate Similarity | NPD3815 | Phase 1 |
0.7078 | Intermediate Similarity | NPD3816 | Phase 1 |
0.707 | Intermediate Similarity | NPD7729 | Clinical (unspecified phase) |
0.7068 | Intermediate Similarity | NPD6531 | Approved |
0.7068 | Intermediate Similarity | NPD6530 | Approved |
0.7061 | Intermediate Similarity | NPD3389 | Approved |
0.7061 | Intermediate Similarity | NPD3394 | Approved |
0.7061 | Intermediate Similarity | NPD3393 | Approved |
0.7059 | Intermediate Similarity | NPD7853 | Phase 2 |
0.7054 | Intermediate Similarity | NPD6517 | Phase 3 |
0.7052 | Intermediate Similarity | NPD4328 | Approved |
0.7051 | Intermediate Similarity | NPD4418 | Discontinued |
0.705 | Intermediate Similarity | NPD4558 | Phase 2 |
0.7047 | Intermediate Similarity | NPD6625 | Approved |
0.7047 | Intermediate Similarity | NPD6494 | Phase 2 |
0.7045 | Intermediate Similarity | NPD7194 | Discontinued |
0.7023 | Intermediate Similarity | NPD7588 | Discontinued |
0.7022 | Intermediate Similarity | NPD7689 | Approved |
0.7021 | Intermediate Similarity | NPD6550 | Discontinued |
0.702 | Intermediate Similarity | NPD6963 | Approved |
0.702 | Intermediate Similarity | NPD6964 | Approved |
0.702 | Intermediate Similarity | NPD3257 | Approved |
0.702 | Intermediate Similarity | NPD5417 | Clinical (unspecified phase) |
0.7016 | Intermediate Similarity | NPD6790 | Phase 1 |
0.7012 | Intermediate Similarity | NPD5429 | Discontinued |
0.7012 | Intermediate Similarity | NPD3263 | Phase 3 |
0.7008 | Intermediate Similarity | NPD7069 | Discontinued |
0.7008 | Intermediate Similarity | NPD5866 | Approved |
0.6996 | Remote Similarity | NPD5801 | Clinical (unspecified phase) |
0.6992 | Remote Similarity | NPD5003 | Discontinued |
0.6992 | Remote Similarity | NPD8149 | Discontinued |
0.698 | Remote Similarity | NPD7558 | Phase 2 |
0.6979 | Remote Similarity | NPD3324 | Clinical (unspecified phase) |
0.6977 | Remote Similarity | NPD8017 | Clinical (unspecified phase) |
0.6977 | Remote Similarity | NPD8016 | Phase 3 |
0.6976 | Remote Similarity | NPD3258 | Approved |
0.6971 | Remote Similarity | NPD3003 | Approved |
0.6967 | Remote Similarity | NPD5416 | Discontinued |
0.6964 | Remote Similarity | NPD7823 | Clinical (unspecified phase) |
0.6958 | Remote Similarity | NPD7064 | Clinical (unspecified phase) |
0.6951 | Remote Similarity | NPD7538 | Clinical (unspecified phase) |
0.6948 | Remote Similarity | NPD8479 | Phase 2 |
0.6948 | Remote Similarity | NPD7858 | Clinical (unspecified phase) |
0.6944 | Remote Similarity | NPD7426 | Phase 1 |
0.6942 | Remote Similarity | NPD7222 | Phase 2 |
0.6939 | Remote Similarity | NPD6657 | Clinical (unspecified phase) |
0.6933 | Remote Similarity | NPD6874 | Approved |
0.693 | Remote Similarity | NPD3920 | Phase 2 |
0.6929 | Remote Similarity | NPD3946 | Clinical (unspecified phase) |
0.6926 | Remote Similarity | NPD6456 | Discontinued |
0.6917 | Remote Similarity | NPD5005 | Approved |
0.6917 | Remote Similarity | NPD5006 | Approved |
0.6914 | Remote Similarity | NPD2509 | Approved |
0.6914 | Remote Similarity | NPD2510 | Approved |
0.6912 | Remote Similarity | NPD7924 | Phase 2 |
0.6912 | Remote Similarity | NPD7925 | Phase 2 |
0.6905 | Remote Similarity | NPD3925 | Approved |
0.6894 | Remote Similarity | NPD3924 | Approved |
0.6894 | Remote Similarity | NPD3921 | Approved |
0.6894 | Remote Similarity | NPD3922 | Approved |
0.6894 | Remote Similarity | NPD3923 | Approved |
0.6891 | Remote Similarity | NPD4987 | Clinical (unspecified phase) |
0.689 | Remote Similarity | NPD7710 | Clinical (unspecified phase) |
0.6883 | Remote Similarity | NPD4897 | Phase 2 |
0.688 | Remote Similarity | NPD5070 | Clinical (unspecified phase) |
0.6878 | Remote Similarity | NPD5512 | Phase 3 |
0.6875 | Remote Similarity | NPD8310 | Clinical (unspecified phase) |
0.6871 | Remote Similarity | NPD7181 | Phase 3 |
0.6867 | Remote Similarity | NPD4429 | Discontinued |
0.6867 | Remote Similarity | NPD7878 | Phase 2 |
0.6866 | Remote Similarity | NPD8461 | Discontinued |
0.6865 | Remote Similarity | NPD7547 | Clinical (unspecified phase) |
0.6863 | Remote Similarity | NPD5022 | Discontinued |
0.6857 | Remote Similarity | NPD5914 | Approved |
0.6855 | Remote Similarity | NPD5612 | Discontinued |
0.6853 | Remote Similarity | NPD5506 | Approved |
0.6853 | Remote Similarity | NPD5507 | Approved |
0.6844 | Remote Similarity | NPD8359 | Phase 2 |
0.6844 | Remote Similarity | NPD6376 | Discontinued |
0.6844 | Remote Similarity | NPD6460 | Clinical (unspecified phase) |
0.6834 | Remote Similarity | NPD4958 | Clinical (unspecified phase) |
0.6829 | Remote Similarity | NPD4502 | Phase 2 |
0.6828 | Remote Similarity | NPD8255 | Phase 2 |
0.682 | Remote Similarity | NPD7777 | Approved |
0.682 | Remote Similarity | NPD7778 | Approved |
0.682 | Remote Similarity | NPD4420 | Approved |
0.682 | Remote Similarity | NPD53 | Approved |
0.6802 | Remote Similarity | NPD7225 | Discontinued |
0.68 | Remote Similarity | NPD8405 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD6985 | Discontinued |
0.6795 | Remote Similarity | NPD5891 | Approved |
0.6784 | Remote Similarity | NPD3259 | Approved |
0.6783 | Remote Similarity | NPD6723 | Discontinued |
0.6783 | Remote Similarity | NPD7922 | Phase 1 |
0.678 | Remote Similarity | NPD8468 | Phase 2 |
0.678 | Remote Similarity | NPD8100 | Phase 3 |
0.6776 | Remote Similarity | NPD2916 | Discontinued |
0.6773 | Remote Similarity | NPD6974 | Phase 3 |
0.6773 | Remote Similarity | NPD3763 | Approved |
0.6772 | Remote Similarity | NPD7719 | Discontinued |
0.677 | Remote Similarity | NPD7688 | Phase 1 |
0.6767 | Remote Similarity | NPD6244 | Phase 3 |
0.6767 | Remote Similarity | NPD6243 | Phase 3 |
0.6765 | Remote Similarity | NPD6861 | Clinical (unspecified phase) |
0.676 | Remote Similarity | NPD4989 | Phase 2 |
0.6755 | Remote Similarity | NPD3328 | Phase 2 |
0.6749 | Remote Similarity | NPD2121 | Clinical (unspecified phase) |
0.6735 | Remote Similarity | NPD7453 | Approved |
0.6735 | Remote Similarity | NPD7452 | Approved |
0.6733 | Remote Similarity | NPD8109 | Clinical (unspecified phase) |
0.6732 | Remote Similarity | NPD8052 | Clinical (unspecified phase) |
0.6729 | Remote Similarity | NPD8442 | Discontinued |
0.6722 | Remote Similarity | NPD1768 | Approved |
0.6721 | Remote Similarity | NPD5901 | Discontinued |
0.6721 | Remote Similarity | NPD4997 | Clinical (unspecified phase) |
0.6707 | Remote Similarity | NPD7947 | Clinical (unspecified phase) |
0.6705 | Remote Similarity | NPD7620 | Phase 2 |
0.6705 | Remote Similarity | NPD4846 | Phase 2 |
0.6704 | Remote Similarity | NPD8101 | Phase 3 |
0.6694 | Remote Similarity | NPD5530 | Phase 1 |
0.6694 | Remote Similarity | NPD7958 | Clinical (unspecified phase) |
0.6694 | Remote Similarity | NPD7957 | Phase 1 |
0.6693 | Remote Similarity | NPD5559 | Phase 2 |
0.6692 | Remote Similarity | NPD6276 | Discontinued |
PubChem CID   | 8550 |
ChEMBL   | CHEMBL1200515 |
ZINC   |
Molecular Weight:   | 578.26 |
ALogP:   | -0.8124 |
MLogP:   | 3.88 |
XLogP:   | 3.438 |
# Rotatable Bonds:   | 14 |
Polar Surface Area:   | 108.55 |
# H-Bond Aceptor:   | 7 |
# H-Bond Donor:   | 1 |
# Rings:   | 6 |
# Heavy Atoms:   | 42 |